Leadership Overview
Alcami has 7 executives leading key functions including strategy, operations, information technology, human resources, and product development.
Driven by a commitment to advancing pharmaceutical and biotech innovation, Alcami leverages extensive experience and facilities to provide comprehensive solutions across the entire product development lifecycle, solidifying its market impact.
Driven by a commitment to advancing pharmaceutical and biotech innovation, Alcami leverages extensive experience and facilities to provide comprehensive solutions across the entire product development lifecycle, solidifying its market impact.
Leadership Roles at Alcami
Roz Stone - Earthware Enterprise Chief Executive Officer
Roz Stone, the Earthware Enterprise Chief Executive Officer at Alcami, directs the overarching strategic vision and operational framework for the organization. Stone's leadership guides Alcami's mission to advance pharmaceutical and biotech products through every development stage. This executive function involves setting corporate objectives, fostering innovation across all service lines, and ensuring alignment with market demands. The Earthware Enterprise Chief Executive Officer oversees the integration of diverse operational units, from analytical development to commercial manufacturing, ensuring seamless execution of client projects. Stone's strategic direction maximizes Alcami's 675,000 ft of facilities across the United States, driving efficiency and growth. This critical role ensures Alcami maintains its position as a leading contract development and manufacturing organization, delivering customizable and innovative solutions to a global client base. Roz Stone's executive oversight is fundamental to Alcami's sustained success and market leadership.
Guy Kubi - Chief Operating Officer
Guy Kubi, the Chief Operating Officer at Alcami, executes the day-to-day operational strategies across the company's extensive network. Kubi directs all aspects of Alcami's service delivery, including analytical development, clinical to commercial sterile and oral solid manufacturing, and packaging operations. This executive responsibility encompasses optimizing resource allocation within the 675,000 ft of facilities located throughout the United States. The Chief Operating Officer ensures adherence to stringent cGMP standards in biostorage, environmental monitoring, and pharmaceutical support services. Guy Kubi's focus remains on enhancing operational efficiency, driving process improvements, and maintaining the highest quality standards for pharmaceutical and biotech clients. This leadership position is crucial for translating strategic objectives into tangible operational outcomes, ensuring Alcami consistently meets client needs and project timelines. Kubi's operational command underpins Alcami's capacity to advance products through every lifecycle stage.

Scott Chadwick - President
Scott Chadwick, the President at Alcami, drives strategic growth and market expansion for the organization. Chadwick oversees key business development initiatives and client relationship management, ensuring Alcami's services meet the evolving needs of the pharmaceutical and biotech industries. This executive position involves fostering partnerships and identifying new opportunities to leverage Alcami's comprehensive development and manufacturing capabilities. The President plays a crucial role in aligning corporate strategy with operational execution across the company's extensive facilities. Scott Chadwick's leadership focuses on enhancing Alcami's market presence and delivering exceptional value to clients navigating product lifecycles. This role is instrumental in championing Alcami's commitment to innovation and quality, supporting the advancement of critical healthcare solutions. Chadwick's presidency guides Alcami's trajectory toward continued industry leadership.
Katie Schlipp - President, Laboratory Operations
Katie Schlipp, the President of Laboratory Operations at Alcami, directs the strategic and operational oversight of all analytical and microbiology services. Schlipp ensures the highest standards of quality and compliance are maintained across Alcami's laboratory functions, supporting pharmaceutical and biotech clients from early development through commercialization. This executive role involves managing complex analytical development projects, environmental monitoring programs, and cGMP biostorage solutions. The President of Laboratory Operations focuses on optimizing laboratory workflows, implementing cutting-edge technologies, and fostering scientific excellence within the teams. Katie Schlipp's leadership is critical for delivering accurate, reliable data and innovative solutions that accelerate product development timelines. This position ensures Alcami's laboratory capabilities remain at the forefront of the industry, supporting the company's comprehensive service portfolio across its US-based facilities. Schlipp's dedication drives the precision essential for client success.

Tori Arens - President, Drug Product
Tori Arens, the President of Drug Product at Alcami, leads the strategic direction and operational execution of sterile and oral solid dosage manufacturing. Arens oversees the end-to-end production processes, ensuring Alcami delivers high-quality, compliant drug products for pharmaceutical and biotech clients. This executive responsibility encompasses managing clinical to commercial manufacturing campaigns, packaging services, and supply chain logistics. The President of Drug Product focuses on driving efficiency, implementing advanced manufacturing technologies, and maintaining rigorous quality control throughout production. Tori Arens' leadership is essential for translating client needs into successful manufacturing outcomes, supporting product lifecycle advancement. This role ensures Alcami's manufacturing facilities operate at peak performance, providing reliable and innovative solutions. Arens' expertise is fundamental to Alcami's reputation for excellence in drug product development and commercial supply.
Tariq Jamal - Chief Information Officer
Tariq Jamal, the Chief Information Officer at Alcami, architects the company's technology infrastructure and digital strategy. Jamal directs the implementation and management of all IT systems, ensuring robust cybersecurity measures and data integrity across Alcami's operations. This executive role is pivotal in supporting the company's extensive service offerings, including analytical development, manufacturing, and biostorage. The Chief Information Officer oversees the integration of advanced technological solutions to enhance operational efficiency and client collaboration. Tariq Jamal's leadership ensures that Alcami's digital capabilities align with its mission to provide innovative solutions to pharmaceutical and biotech partners. This position is critical for maintaining seamless communication and data flow across the 675,000 ft of facilities, supporting every stage of product development. Jamal's strategic technology vision empowers Alcami's continued growth and service excellence.
Rose-Marie Nelson - Chief Human Resources Officer
Rose-Marie Nelson, the Chief Human Resources Officer at Alcami, leads all human capital strategies and organizational development initiatives. Nelson directs the recruitment, retention, and professional growth of Alcami's workforce, ensuring a skilled and motivated team supports the company's mission. This executive function is vital for cultivating a culture of innovation and excellence across all departments, from manufacturing to laboratory operations. The Chief Human Resources Officer oversees employee relations, compensation, benefits, and compliance with labor laws, ensuring a supportive and productive work environment. Rose-Marie Nelson's strategic approach to human resources strengthens Alcami's ability to deliver complex pharmaceutical and biotech solutions. This role is fundamental to managing the talent required to operate 675,000 ft of facilities and advance products through every development stage. Nelson's leadership ensures Alcami possesses the human expertise necessary for sustained success.

Explore Leadership Teams in Manufacturing
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The company invests heavily in research and development, maintaining a robust pipeline of innovative medicines and diagnostic solutions while collaborating with academic institutions, biotechnology companies, and healthcare partners worldwide. Headquartered in Basel, Switzerland, Roche operates globally with a presence in numerous countries, employing a diverse workforce of scientists, researchers, healthcare professionals, and business experts dedicated to transforming patient care and making a meaningful difference in the fight against serious diseases.
Company Leadership IL
NA
RL
PB
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
MM
MP
CM
Lonza is a global supplier serving the pharmaceutical, biotech, and specialty ingredients markets. The company provides a broad portfolio of services and products, including active pharmaceutical ingredients, drinking water sanitizers, nutritional and personal care ingredients, agricultural solutions, industrial preservatives, and microbial control technologies that address harmful viruses, bacteria, and other pathogens. Founded in the Swiss Alps, Lonza operates through two primary market-focused segments — Pharma & Biotech and Specialty Ingredients — reflecting its commitment to innovation and global health advancement.
Company Leadership JO
RW
MM
Kite Pharma, founded in 2009, is a pharmaceutical company specializing in cell therapy to treat and potentially cure cancer. The company focuses on engineered T cell therapy for hematologic malignancies and is committed to making these innovative treatments accessible to eligible patients. Unlike traditional pharmaceutical manufacturing, Kite Pharma's approach involves reengineering a patient's own immune cells to fight cancer cells individually. The company operates dedicated cell therapy manufacturing facilities in California, Maryland, and the Netherlands, with corporate headquarters in Santa Monica, California. Kite Pharma continues to advance cancer immunotherapy through its specialized treatments and research.
Company Leadership LM
KD
NS